About this medicine
- Approved name
- Synapse
About this procedure
- Current status
- European Commission final decision
- Reference number
- EMEA/H/A-31/1529
- Type
- Article 31 referrals
This type of referral is triggered when the interest of the Union is involved, following concerns relating to the quality, safety or efficacy of a medicine or a class of medicines.
- Authorisation model
- Nationally authorised product(s)
- Decision making model
- CHMP-EC
Key dates and outcomes
- CHMP opinion date
- 21/03/2024
- EC decision date
- 24/05/2024